To better analyze AhRR and PPP1R3C’s role in treatment responses, we investigated whether AhRR and PPP1R3C expression also correlates with ovarian cancer patients’ progression-free survival (PFS). This evidence concerns the gene PPP1R3C and ovarian carcinoma.